Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 14/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 9/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 8/20 | 0.35 |
| ▸ | PPARD | Q03181 | 7/20 | 0.34 |
| ▸ | PPARG | P37231 | 5/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6404754 | 0.89 | NR1H2 (0.48) | NR1H2NR1H3GRM2PPARAPPARD | |
| SCHEMBL6405846 | 0.85 | NR1H2 (0.64) | NR1H2NR1H3GRM2PPARAPPARD | |
| SCHEMBL6405155 | 0.85 | NR1H2 (0.52) | NR1H2NR1H3PPARAPPARDPPARG | |
| SCHEMBL6098942 | 0.84 | GRM2 (0.55) | NR1H2NR1H3GRM2PPARAPPARD | |
| SCHEMBL6407458 | 0.81 | NR1H2 (0.41) | NR1H2NR1H3GRM2PPARAPPARD | |
| SCHEMBL6405513 | 0.81 | NR1H2 (0.44) | NR1H2NR1H3GRM2PPARAPPARD | |
| SCHEMBL6411684 | 0.80 | NR1H2 (0.57) | NR1H2NR1H3 | |
| SCHEMBL6100417 | 0.78 | NR1H2 (0.73) | NR1H2NR1H3PPARAPPARDPPARG | |
| SCHEMBL6405323 | 0.73 | NR1H2 (0.55) | NR1H2NR1H3PPARAPPARDPPARG | |
| SCHEMBL5576769 | 0.72 | NR1H2 (0.56) | NR1H2NR1H3GRM2PPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1534696-A1 | THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS | Merck & Co., Inc. (US) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004011448-A1 | THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS | MERCK & CO., INC. (US) | 2004-02-05 | — | — | WO | disclosed |